Powered by

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of FibroGen Inc. (FGEN) on Behalf of Investors

Apr 07, 2021 - Business Wire

Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of FibroGen Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN ) investors concerning the Company's possible violations of the federal securities laws.

If you suffered a loss on your FibroGen investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact...